This in vitro observation was confirmed by the higher levels of CXCR4 detected in NK cells and monocytes of chronic myeloid leukemia (CML) patients treated with TKI [125]. The gene discussed is CXCR4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.